No AbstractPARIS - Hybrigenics SA has been granted a refundable subsidy of €1.4 million (US$2 million) by France's state agency for promoting innovation and supporting small and medium-sized enterprises, OSEO, to finance the development of inecalcitol as a treatment for prostate cancer.